Last reviewed · How we verify
Pulmonary emphysema
Approved treatments
- Cutivate · Teva Pharm
- Foradil · Novartis
Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Incruse Ellipta · Glaxo Grp England
Umeclidinium works by blocking the M4 muscarinic acetylcholine receptor to relax airway smooth muscle and improve breathing. - Spiriva · Boehringer Ingelheim
Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways. - Breo Ellipta · Glaxo Grp Ltd
Breo Ellipta works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Brovana · Lupin
Brovana works by activating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Flonase · GSK (GlaxoSmithKline)
- Arnuity Ellipta · Haleon Us Holdings
- Butanefrine
Butanefrine works by stimulating the body's natural responses to constrict blood vessels and increase airway resistance. - Flixotide · Mundipharma Research Limited
- Fluticason · Creighton University
- Theophyllin · University of Bergen
- Epipen · Pfizer Inc.
Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation. - Norepinephrine Bitartrate In 5% Dextrose · Pfizer
Norepinephrine constricts blood vessels and stimulates the heart. - Atrovent
- Bupivacaine Hydrochloride And Epinephrine · Pfizer Inc.
Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels. - Diphyllin
- Metaproterenol
- Brethine
- Tornalate · Sanofi
- UMEC · Glaxo Grp England
UmeC is a small molecule drug that works by interacting with a specific target in the body. - Incruse · Fundacio Privada Mon Clinic Barcelona
- Serevent · Fundacio Privada Mon Clinic Barcelona
- Epinephrin · United States Naval Medical Center, San Diego
- Brovana · Wake Forest University Health Sciences
- Aminophyllin · University of Padova
- Noradrenaline · Tanta University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary emphysema patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary emphysema treatment landscape brief
- Pulmonary emphysema treatment updates RSS
Frequently asked questions about Pulmonary emphysema
What drugs treat Pulmonary emphysema?
Tracked treatments include Cutivate, Foradil, Incruse Ellipta, Spiriva, Breo Ellipta, Brovana, Flonase, Arnuity Ellipta.
What is the treatment for Pulmonary emphysema?
Standard treatment for Pulmonary emphysema includes Cutivate, Foradil, Incruse Ellipta, Spiriva, Breo Ellipta. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pulmonary emphysema patent cliff · Pulmonary emphysema CI report
- Treatment: Cutivate · Teva Pharm
- Treatment: Foradil · Novartis
- Treatment: Incruse Ellipta · Glaxo Grp England
- Treatment: Spiriva · Boehringer Ingelheim
- Treatment: Breo Ellipta · Glaxo Grp Ltd
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing